Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / engagement-letter-gdt.docx
engagement-letter-gdt.docx
Parties
HARKNESS LLP
Counsel Genome Dx Therapeutics Inc
Genome Dx Therapeutics Inc
Scope Inc
Canfield Document Solutions LLC
Dates
March 12, 2025
October 8, 2019
December 21, 2021
February 6, 2024
October 7, 2024
Amounts
$350.00
$475.00
$6,800,000
$9,200,000
$1,400,000
$1,800,000
$5,000
$10,000,000
$2,500,000
$1,350.00
Obligations
Unless otherwise agreed in a separate written instrument signed by both parties, the terms set forth herein shall govern the entirety of the Firm's representation of GenomeDx with respect to the matter described below
During the pendency of any billing dispute, all undisputed amounts shall remain due and payable in accordance with the payment terms set forth herein, and the accrual of interest on undisputed amounts shall not be suspended
Confidentiality All information provided by GenomeDx to C&H in connection with this engagement, whether oral, written, or electronic, is and shall remain subject to the protections of the attorney-client privilege and/or the work-product doctrine, to the fullest extent recognized by applicable law
Limitation of Liability To the fullest extent permitted by applicable law and consistent with applicable rules of professional conduct, C&H's aggregate liability to GenomeDx arising out of or relating to this engagement, whether based on contract, tort, breach of fiduciary duty, or any other theory of liability, shall not exceed the total amount of professional fees actually paid by GenomeDx to C&H under this Engagement Letter
This limitation shall not apply in cases of the Firm's willful misconduct or gross negligence
Nothing in this Section 11 shall be construed to limit or modify GenomeDx's rights under applicable rules of professional conduct or to waive any non-waivable rights under applicable law